Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Fucoxanthin, a major carotenoid in brown sea algae, has recently been demonstrated by us to inhibit the proliferation of colon cancer cells, and this effect was associated with growth arrest. These results, taken together with previous studies with fucoxanthin, suggest that it may be useful in chemoprevention of other human malignancies. The present study was designed to evaluate the molecular mechanisms of fucoxanthin against hepatic cancer using the human hepatocarcinoma HepG2 cell line (HepG2). Fucoxanthin reduced the viability of HepG2 cells accompanied with the induction of cell cycle arrest during the G0/G1 phase at 25 microM. This concentration of fucoxanthin inhibited the phosphorylation of the retinoblastoma protein (Rb) at Serine 780 (Ser780) position 18 h after treatment. The kinase activity of cyclin D and cdk4 complex, responsible for the phosphorylation of Rb Ser780 site, was down-regulated 18 h after the treatment. Western blotting analysis revealed that the expression of cyclin D-type protein was suppressed by treatment of fucoxanthin. This reduction was partially blocked by concurrent treatment with the proteasome inhibitor MG132, indicating the involvement of the proteasome-mediated degradation. In addition, RT-PCR analysis revealed that fucoxanthin also appeared to repress cyclin D mRNA. Thus, both the protein degradation and transcriptional repression seem to be responsible for suppressed cyclin D level in fucoxanthin-treated HepG2 cells which may be related to the antitumorgenic activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 1×
“proteasome in an ubiquitin-dependent manner [41, 43].”
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690 · cited 1×
“The growth of cells is normally determined by extracellular signals that control the gene expression and protein regulation required for cell division [14].”
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746 · cited 2×
“Fucoxanthin induces proteolysis of both cyclin D1 and cyclin D3 Since cyclins tagged with ubiquitin are usually recognized and degraded by the 26S proteasome [41], the proteasomal activity was measured in fucoxanthin-treated HepG2 cells by using a fluorogenic substrate.”
Apoptosis-inducing effect of fucoxanthin on human leukemia cell line HL-60
HOSOKAWA, M., WANEZAKI, S., MIYAUCHI, K., KURIHARA, H., KOHNO, H., KAWABATA, J., ODASHIMA, S., & TAKAHASHI, K. (1999) · Food Science and Technology Research · doi:10.3136/fstr.5.243 · Cited by 173
Cited by
Peng, J., Yuan, J.-P., Wu, C.-F., & Wang, J.-H. (2011) · Marine Drugs · doi:10.3390/md9101806 · Cited by 820
“[16], who found that the growth-inhibitory effect of fucoxanthin on the cancer cells was chiefly due to an arrest in the”
BackgroundLordan, S., Ross, R. P., & Stanton, C. (2011) · Marine Drugs · doi:10.3390/md9061056 · Cited by 748
Cancer Chemoprevention by Carotenoids
Tanaka, T., Shnimizu, M., & Moriwaki, H. (2012) · Molecules · doi:10.3390/molecules17033202 · Cited by 589
Terpenoids as potential chemopreventive and therapeutic agents in liver cancer
Thoppil, R. J. (2011) · World Journal of Hepatology · doi:10.4254/wjh.v3.i9.228 · Cited by 353
Carotenoids: potential allies of cardiovascular health?
Maria, A. G., Graziano, R., & Nicolantonio, D. (2015) · Food & Nutrition Research · doi:10.3402/fnr.v59.26762 · Cited by 323
Anti-Obesity Activity of the Marine Carotenoid Fucoxanthin
Gammone, M., & D'Orazio, N. (2015) · Marine Drugs · doi:10.3390/md13042196 · Cited by 321
Kim, K.-N., Heo, S.-J., Yoon, W.-J., Kang, S.-M., Ahn, G., Yi, T.-H., & Jeon, Y.-J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.032 · Cited by 308
Fucoxantin: A Treasure from the Sea
D’Orazio, N., Gemello, E., Gammone, M. A., De Girolamo, M., Ficoneri, C., & Riccioni, G. (2012) · Marine Drugs · doi:10.3390/md10030604 · Cited by 303
Carotenoids: Sources, medicinal properties and their application in food and nutraceutical industry
Jaswir, I. (2011) · Journal of Medicinal Plants Research · doi:10.5897/jmprx11.011 · Cited by 278
The Potential of Microalgae for the Production of Bioactive Molecules of Pharmaceutical Interest
Mimouni, V., Ulmann, L., Pasquet, V., Mathieu, M., Picot, L., Bougaran, G., Cadoret, J.-P., Morant-Manceau, A., & Schoefs, B. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112804724828 · Cited by 270
Fucoxanthin: A Marine Carotenoid Exerting Anti-Cancer Effects by Affecting Multiple Mechanisms
Kumar, S., Hosokawa, M., & Miyashita, K. (2013) · Marine Drugs · doi:10.3390/md11125130 · Cited by 246
“The arrest of the cell cycle in the G0/G1 stage by fucoxanthin has been observed in many studies involving different cell lines [10,14,15,31,32,43–46] while Yu et al.”
BackgroundBraconi, C., Valeri, N., Kogure, T., Gasparini, P., Huang, N., Nuovo, G. J., Terracciano, L., Croce, C. M., & Patel, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011098108 · Cited by 214
Phycochemical Constituents and Biological Activities of Fucus spp.
Catarino, M. D., Silva, A. M. S., & Cardoso, S. M. (2018) · Marine Drugs · doi:10.3390/md16080249 · Cited by 203
Zorofchian Moghadamtousi, S., Karimian, H., Khanabdali, R., Razavi, M., Firoozinia, M., Zandi, K., & Abdul Kadir, H. (2014) · The Scientific World Journal · doi:10.1155/2014/768323 · Cited by 178
Lin, J., Huang, L., Yu, J., Xiang, S., Wang, J., Zhang, J., Yan, X., Cui, W., He, S., & Wang, Q. (2016) · Marine Drugs · doi:10.3390/md14040067 · Cited by 142
Production of fucoxanthin by the microalga Tisochrysis lutea: A review of recent developments
Mohamadnia, S., Tavakoli, O., Faramarzi, M. A., & Shamsollahi, Z. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2019.734637 · Cited by 78
Metadata
- Authors
- Das, S. K., Hashimoto, T., & Kanazawa, K.
- Venue
- Biochimica et Biophysica Acta (BBA) - General Subjects
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 1780
- Issue
- 4
- Pages
- 743-749
- ISSN
- 0304-4165 (ISSN-L)
- OpenAlex
- W2030027307
- Cited by
- 148
- References
- 5
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.